What does Nuvation Bio, Inc. do?

Jun 22 2025 07:09 PM IST
share
Share Via
Nuvation Bio, Inc. is a micro-cap biotechnology company focused on opportunities in the pharmaceuticals sector, with recent net sales of $3 million and a net loss of $53 million. The company has a market cap of $581.85 million and does not currently pay dividends.
Overview:
Nuvation Bio, Inc. is a biotechnology company focused on identifying and acquiring opportunities within the pharmaceuticals and biotechnology sector, categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 3 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -53 Million (Quarterly Results - Mar 2025)
Market cap: USD 581.85 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.08
Return on Equity: -43.17%
Price to Book: 1.39

Contact Details:
Address: 357 Tehama Street, Floor 3, SAN FRANCISCO CA: 94103
Tel: 1 415 7543517
Fax: 1 302 6365454
Website: https://panacea.ecor1cap.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News